Patent holdings for IPC class A61K 31/7012

Total number of patents in this class: 308

10-year publication summary

18
35
19
25
13
22
23
20
12
8
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Glycom A/S
251
13
LifeScience AS
10
10
Regeneron Pharmaceuticals, Inc.
4312
7
The United States of America, as represented by the Secretary, Department of Health and Human Services
2866
6
Life Science Nutrition AS
12
5
MedImmune, LLC
495
5
Ultragenyx Pharmaceutical Inc.
176
5
Shandong Zhonghai Pharmaceutical CO. LTD
8
5
The Regents of the University of California
20035
4
AMOREPACIFIC Corporation
2847
4
Australian Biomedical Company Pty Ltd.
5
4
Meiji Co., Ltd.
728
4
Nippon Zoki Pharmaceutical Co., Ltd.
142
4
Applied Biological Laboratories, Inc.
15
4
Locus IP Company LLC
97
4
B & H Biotechnologies, LLC
16
4
Nestec S.A.
2657
3
ACP Japan Co., Ltd.
74
3
The Chancellor, Masters and Scholars of The University of Oxford
159
3
Curemark, LLC
74
3
Other owners 208